U.S. flag

An official website of the United States government

NM_007103.4(NDUFV1):c.1268C>T (p.Thr423Met) AND Leigh syndrome

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Nov 28, 2022
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV002468969.1

Allele description [Variation Report for NM_007103.4(NDUFV1):c.1268C>T (p.Thr423Met)]

NM_007103.4(NDUFV1):c.1268C>T (p.Thr423Met)

Genes:
LOC126861242:CDK7 strongly-dependent group 2 enhancer GRCh37_chr11:67379204-67380403 [Gene]
NDUFV1:NADH:ubiquinone oxidoreductase core subunit V1 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
11q13.2
Genomic location:
Preferred name:
NM_007103.4(NDUFV1):c.1268C>T (p.Thr423Met)
Other names:
p.T423M:ACG>ATG
HGVS:
  • NC_000011.10:g.67612225C>T
  • NG_013353.1:g.10374C>T
  • NM_001166102.2:c.1241C>T
  • NM_007103.4:c.1268C>TMANE SELECT
  • NP_001159574.1:p.Thr414Met
  • NP_009034.2:p.Thr423Met
  • NC_000011.9:g.67379696C>T
  • NM_001166102.1:c.1241C>T
  • NM_007103.3:c.1268C>T
  • P49821:p.Thr423Met
Protein change:
T414M; THR423MET
Links:
UniProtKB: P49821#VAR_008847; OMIM: 161015.0001; dbSNP: rs121913659
NCBI 1000 Genomes Browser:
rs121913659
Molecular consequence:
  • NM_001166102.2:c.1241C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_007103.4:c.1268C>T - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Leigh syndrome (NULS)
Synonyms:
Leigh Disease; Subacute necrotizing encephalopathy; Necrotizing encephalopathy infantile subacute of Leigh; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0009723; MedGen: C0023264; Orphanet: 506; OMIM: 256000

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV002766344Women's Health and Genetics/Laboratory Corporation of America, LabCorp
criteria provided, single submitter

(LabCorp Variant Classification Summary - May 2015)
Pathogenic
(Nov 28, 2022)
germlineclinical testing

PubMed (4)
[See all records that cite these PMIDs]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Mutant NDUFV1 subunit of mitochondrial complex I causes leukodystrophy and myoclonic epilepsy.

Schuelke M, Smeitink J, Mariman E, Loeffen J, Plecko B, Trijbels F, Stöckler-Ipsiroglu S, van den Heuvel L.

Nat Genet. 1999 Mar;21(3):260-1. No abstract available.

PubMed [citation]
PMID:
10080174

Characterization of clinically identified mutations in NDUFV1, the flavin-binding subunit of respiratory complex I, using a yeast model system.

Varghese F, Atcheson E, Bridges HR, Hirst J.

Hum Mol Genet. 2015 Nov 15;24(22):6350-60. doi: 10.1093/hmg/ddv344. Epub 2015 Sep 7.

PubMed [citation]
PMID:
26345448
PMCID:
PMC4614703
See all PubMed Citations (4)

Details of each submission

From Women's Health and Genetics/Laboratory Corporation of America, LabCorp, SCV002766344.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (4)

Description

Variant summary: NDUFV1 c.1268C>T (p.Thr423Met) results in a non-conservative amino acid change located in the NADH-ubiquinone oxidoreductase 51kDa subunit, iron-sulphur binding domain (IPR019575) of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 1.2e-05 in 251318 control chromosomes. c.1268C>T has been reported in the literature as biallelic compound heterozygous or homozygous genotypes in multiple individuals affected with Leigh Syndrome (example, PMID 33083013, 34716721, 10080174). These data indicate that the variant is very likely to be associated with disease. At least one publication reports experimental evidence evaluating an impact on protein function (example, PMID 26345448). The most pronounced variant effect results in absence of detectable complex I in an apparently homozygous (by cDNA sequencing), but compound heterozygous genotype due to a nonsense variant on the other allele that was not expressed. Eight clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. All laboratories classified the variant as pathogenic/likely pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024